Recently, an intelligent orthopedic team led by Jiang Xieyuan, the director of Beijing Jishuitan Hospital, and Wang Junqiang, the director of the intelligent orthopedic research ward, successfully treated a 90 year old pelvic fracture patient using Tianji orthopedic surgical robot assisted percutaneous pelvic canal screw insertion technology. The percutaneous pelvic canal screw insertion technique is a highly difficult and high-risk surgery. But guided by the millimeter level precision of the Dimensity orthopedic surgical robot, this surgery took a total of 1.5 hours, with intraoperative bleeding of less than 20 milliliters. The incision length for each screw insertion position was about 1.5 centimeters, meeting the surgical expectations. Tianji Orthopedic Surgical Robot is the result of years of deep cultivation in the field of orthopedic surgical robots by Beijing Tianzhihang Medical Technology Co., Ltd. (hereinafter referred to as "Tianzhihang"). A set of data recently released by Tianzhihang shows that as of now, the clinical application of Tianji series orthopedic surgical robots has covered more than 200 medical institutions, and the total number of surgeries completed has exceeded 100000. During an interview with Science and Technology Daily, Ma Min, President and Director of Tianzhihang, said, "The Tianji orthopedic surgical robot has gradually achieved a closed-loop clinical application." Ma Min introduced that the innovation of the Tianji orthopedic surgical robot has achieved "one machine, multiple indications" coverage, including cervical, thoracic, lumbar, and sacral spine surgery, trauma surgery in pelvic, acetabular, limb and other parts, as well as hip and knee joint replacement surgery. This is the world's first "three in one" universal orthopedic surgical robot. According to statistics, by 2024, Tianji orthopedic surgical robots have achieved an average annual surgical volume of over 150 cases per unit, gradually approaching the international standard of 200 surgical robots per year. The number of surgeries will continue to rise When talking about the core advantages of Tianji orthopedic surgical robots, Ma Min said, firstly, to adhere to a completely independent and original technical route and master the core technology; Secondly, it has high reliability and safety, abundant clinical application cases, and strong comprehensive product strength. With the continuous development and application of new generation information technologies such as artificial intelligence, big data, and cloud computing, the medical technology industry will present more intelligent, personalized, and precise characteristics. Ma Min stated that in the future, Tianzhihang will continue to uphold the spirit of persistent original research, integrate innovation into every aspect of product design, research and development, and manufacturing, and promote the widespread application and in-depth development of technologies such as artificial intelligence in the medical field. Although the prospects are bright, Ma Min also admitted that domestic surgical robot companies have not yet had a profit record. "Although the clinical application has completed the closed loop, the commercial logic closed loop is still in the process of exploration and improvement. The whole industry expects government departments to provide more policy support for surgical robots in areas such as medical insurance, fees, and commercial insurance, just like supporting new and special drugs Ma Min said, "Only by opening up the closed loop of business logic can domestic surgical robot companies achieve stability and long-term success